Close Search
JDDonline - Journal of Drugs in Dermatology
  • Home
  • Issues
    • Current Issue
    • eJDD
    • Featured Articles
    • Archived Issues
    • Supplement Library
    • Case Reports
    • Unlocked Access
    • JDD Corner
    • Clinical Solutions
  • Topics
    • Acne
    • Atopic Dermatitis
    • Oats in Skincare
    • Oncoderm
    • Pigmentary Disorders
    • Psoriasis
    • Inclusive Dermatology Atlas
    • Social and Technology
    • Latest News
  • CME
    • CME Activities
  • Multimedia
    • JDD Corner
    • Video Abstracts
    • Podcast
    • Webinars
    • Translational Lecture Series
    • Video Pearls
  • Info
    • About JDD
    • Advertisers
      • Media Kit
      • Podcast Sponsorship
      • Reprints Contact Us
    • Authors
      • Instructions to Authors
      • Submit a Manuscript
      • Author and Peer Review Login
    • Editorial Board
    • Events
    • Contact Editorial
    • Why Publish in the JDD?
    • Institutional, Library, & Corporate Subscriptions
    • Reprints Contact Us
    • SanovaWorks
  • Inclusive Derm Atlas
    • Online Gallery
    • Digital Edition
  • Subscribe Now
  • Log In
  • x-twitter facebook linkedin instagram
Jul 26
Love0

United Arab Emirates Consensus Recommendations for Management of Acne Vulgaris

By Chuck Lin No Comments
INTRODUCTIONAcne vulgaris is a chronic inflammatory disease that affects pilosebaceous units on the face and trunk requiring longitudinal patient management.1,2 It has a multifactorial pathophysiology that involves an altered sebaceous…
Read More
Jul 26
Love0

Safety of Bimekizumab for Plaque Psoriasis: An Expert Consensus Panel

By Chuck Lin No Comments
INTRODUCTIONPlaque psoriasis is a chronic, relapsing systemic illness that has a significant effect on quality of life.1-3 New biologic therapies targeting tumor necrosis factor (TNF), interleukin (IL)-12/23, IL-17, and IL-23…
Read More
Jul 24
Love0

Efficacy and Safety of Secukinumab in the Treatment of Psoriasis in Patients with Skin Phototypes IV to VI

By Chuck Lin No Comments
INTRODUCTIONPsoriasis is a chronic inflammatory disorder primarily affecting the skin and joints. It affects different racial/ethnic groups worldwide with varying prevalence. Although psoriasis has historically been considered to predominately affect…
Read More
Jul 23
Love0

The Impact of At-Home Narrow-Band UVB Phototherapy for Mild-to-Severe Psoriasis: A Retrospective, Multicenter, Observational Study

By Chuck Lin No Comments
INTRODUCTIONNarrow band-ultraviolet B (NB-UVB) light therapy has been shown to be one of the safest, least expensive, and most effective treatments for psoriasis.1 Traditional clinic-based phototherapy is time-consuming, expensive, and…
Read More
Jul 19
Love0

Case Series of Acral and Mucosal Melanoma in a Diverse Patient Population

By Chuck Lin No Comments
INTRODUCTIONMelanoma accounts for only 1% of all skin cancers but is responsible for most skin cancer-related deaths.1 Acral and mucosal melanoma (AMM) accounts for only 4% of all new melanomas…
Read More
Jul 19
Love0

Safety and Tolerance Evaluation of a Suncare Product in Ethnically Diverse Children With Atopic Dermatitis-Prone Skin

By Chuck Lin No Comments
INTRODUCTIONAtopic dermatitis (AD), commonly known as eczema, is a common chronic inflammatory skin condition, characterized by dry, itchy skin, making individuals more susceptible to skin infections and other complications.1 This…
Read More
Jul 18
Love0

The Hidden Costs of Psoriasis: A Population-Based Study Evaluating How Psoriasis Severity Impacts Work Absenteeism

By Chuck Lin No Comments
INTRODUCTIONPsoriasis is a chronic inflammatory skin disease that affects nearly 8 million adults in the United States (US).1 The disease is characterized by sharply demarcated, scaly, erythematous plaques that can…
Read More
Jul 18
Love0

Preference for Cal/BDP Cream or Foam in Patients With Mild to Moderate Plaque Psoriasis

By Chuck Lin No Comments
INTRODUCTIONThe combined use of topical calcipotriol/betamethasone dipropionate (Cal/BDP) is commonly used and demonstrated to be effective for the management of psoriasis. Used in combination, topical calcipotriol, and betamethasone dipropionate confer…
Read More
Jul 17
Love0

Rapid Remission of Plaque Psoriasis With Bimekizumab Treatment

By Chuck Lin No Comments
INTRODUCTIONSome psoriatic disease topical treatments, such as coal tar and salicylic acid, have stood the test of time, being used consistently over the past century.1 However, the landscape of systemic…
Read More
Jul 17
Love0

Comparison of Characteristics Influencing Patient Selection of Sunscreen Between Urban and Rural Regions in the United States

By Chuck Lin No Comments
INTRODUCTIONSunscreen greatly reduces the risk of skin cancer and is recommended as a critical component of sun protection by the American Academy of Dermatology (AAD).1,2 One study found that dermatologists…
Read More
Jul 17
Love0

Real-life Effectiveness and Safety of Guselkumab in Moderate-to-Severe Plaque Psoriasis: A 104-Week Retrospective Single-Center Study

By Chuck Lin No Comments
INTRODUCTIONPsoriasis is a chronic inflammatory disorder affecting up to 2% to 4% of the general population worldwide.1 The treatment of moderate-to-severe psoriasis includes systemic disease-modifying antirheumatic drugs (DMARDs), such as…
Read More
Jul 15
Love0

TikTok and Dermatology: Questioning the Data

By Chuck Lin No Comments
INTRODUCTIONTikTok is a wildly popular social media application with over 1 billion users. With its ever-growing popularity, it has also become a source of dermatological information and misinformation for the…
Read More
« Previous
NextPrevious »

Search page

Advertisement

Popular

  • Ceut up: Incorporating a New OTC Concept into the Acne Armamentarium. October 3, 2025
  • Ceut up: Incorporating a New OTC Concept into the Acne Armamentarium October 3, 2025
  • The Role of Simultaneous Janus Kinase Inhibitor and Biologic Therapy Use for Refractory Atopic Dermatitis October 2, 2025
  • Refractory Pruritus Secondary to Linear IgA Bullous Dermatosis Treated Successfully With Nemolizumab: A Case Report October 1, 2025
  • Tune In, Turn Up, and Celebrate — Happy National Podcast Day! September 30, 2025

Advertisement

News Topics

  • Inclusive Derm Atlas
  • Atopic Dermatitis
  • CME
  • Featured Articles
  • Issue Highlights
  • Oats in Skincare
  • Oncoderm
  • Pigmentary Disorders
  • Psoriasis
  • Skin of Color
CONTACT US     |      FEEDBACK    |      TERMS     |      COOKIE POLICY    |     PRIVACY    |      EDITORIAL POLICY    |     ADVERTISING POLICY  |    MANAGE PREFERENCES  |  YOUR PRIVACY CHOICES

News Topics

  • Inclusive Derm Atlas
  • Atopic Dermatitis
  • CME
  • Featured Articles
  • Issue Highlights
  • Oats in Skincare
  • Oncoderm
  • Pigmentary Disorders
  • Psoriasis
  • Skin of Color
DermAtlas        Derm In-Review         PDE        Next Steps in Derm         Skin of Color Update     ODAC Dermatology, Aesthetic & Surgical Conference

Journal of Drugs in Dermatology

  • About Us
  • Contact Us
  • Contact Sales
  • Editorial Board
  • eJDD
  • Institutional, Library, & Corporate Subscriptions
  • Log In
  • Open Access
  • Permissions Request
  • Podcast Sponsorship
  • Subscription Info
  • Store

© 2025 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.

  • twitter
  • facebook
  • linkedin
  • instagram
Close Menu
  • Home
  • Issues
    • Current Issue
    • eJDD
    • Featured Articles
    • Archived Issues
    • Supplement Library
    • Case Reports
    • Unlocked Access
    • JDD Corner
    • Clinical Solutions
  • Topics
    • Acne
    • Atopic Dermatitis
    • Oats in Skincare
    • Oncoderm
    • Pigmentary Disorders
    • Psoriasis
    • Inclusive Dermatology Atlas
    • Social and Technology
    • Latest News
  • CME
    • CME Activities
  • Multimedia
    • JDD Corner
    • Video Abstracts
    • Podcast
    • Webinars
    • Translational Lecture Series
    • Video Pearls
  • Info
    • About JDD
    • Advertisers
      • Media Kit
      • Podcast Sponsorship
      • Reprints Contact Us
    • Authors
      • Instructions to Authors
      • Submit a Manuscript
      • Author and Peer Review Login
    • Editorial Board
    • Events
    • Contact Editorial
    • Why Publish in the JDD?
    • Institutional, Library, & Corporate Subscriptions
    • Reprints Contact Us
    • SanovaWorks
  • Inclusive Derm Atlas
    • Online Gallery
    • Digital Edition
  • Subscribe Now
  • Log In

Search